Understanding Sanofi's Issued Shares and Voting Rights Overview
Sanofi's Shares and Voting Rights Insight
Sanofi, a prominent name in the pharmaceutical industry, provides insightful updates regarding the total number of voting rights and issued shares. This information is vital for investors and stakeholders to understand the dynamics of their investment in the company.
Overview of Sanofi
Sanofi is a French société anonyme with a registered share capital amounting to €2,452,461,656. Their registered office is located at 46, avenue de la Grande Armée, Paris. Sanofi is registered at the Paris Commercial and Companies Registry under number 395 030 844, establishing itself as a credible entity within the market.
Key Financial Figures
In the latest update, specific figures were revealed regarding the total number of issued shares and voting rights, illustrating the company's current standings. On April 30, 2025, Sanofi reported having:
- Total number of issued shares: 1,226,230,828
- Number of real voting rights (excluding treasury shares): 1,348,348,742
- Theoretical number of voting rights (including treasury shares): 1,359,092,889
These statistics are not just numbers; they form the backbone of shareholders' voting power and their influence in decision-making processes within the company.
Investor Relations and Communications
For those keen on staying informed about Sanofi's corporate updates, the company maintains a dedicated Investor Relations department. Investors can reach out for any inquiries regarding shares and voting rights through their email at investor.relations@sanofi.com.
Accessible Information
Sanofi ensures that vital information regarding its regulatory updates is easily accessible. Investors can routinely check the company's official website under the "Regulated Information in France" section for the latest announcements concerning shares and voting rights.
Conclusion
In closing, Sanofi's commitment to transparency in providing information regarding shares and voting rights strengthens the trust of investors in the pharmaceutical giant. With the latest reported figures, stakeholders can make informed decisions based on the clear and direct insights provided. Keeping abreast of this information is crucial for current and potential investors alike.
Frequently Asked Questions
What is the total number of issued shares for Sanofi as of April 2025?
As of April 30, 2025, the total number of issued shares for Sanofi is 1,226,230,828.
How many real voting rights does Sanofi have excluding treasury shares?
Sanofi has 1,348,348,742 real voting rights, excluding treasury shares.
What is the theoretical number of voting rights including treasury shares?
The theoretical number of voting rights for Sanofi, including treasury shares, is 1,359,092,889.
How can I contact Sanofi’s Investor Relations?
You can reach Sanofi's Investor Relations department via email at investor.relations@sanofi.com.
Where can I find Sanofi's regulated information?
Sanofi provides regulated information on their official website under the "Regulated Information in France" section, making it accessible for investors to stay updated.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
